home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  
 

registry of biomedical companies

 
  April 23, 2024
promoting the transfer of scientific know-how between industry and academia
 
 
Registry of biomedical companies:

[3] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 467 active entries

N-Life Inc.

PO BOX 98
Darien, 06820
United States of America, Connecticut

Phone: 203 323 6284
Fax: 203 323 0269
E-Mail: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it

Description:

N-LIFE INC is a biotechnology, nanotechnology, wavefront optics and a chromorestructuring genomics company. It holds the rights to the correction of Presbyopia. In 1997 the company acquired the rights and interests
in certain research in chromosomes and mapping from NORTH AMERICAN GENTICS and in 1998 the company acquired the similar information from ALL ASIA GENE POOL based in
Delhi India. The company is committed to the rapid deployment of genomics in a gene therapy. The company is a memeber of University of San Diego Connect and the NATIONAL AUSTRALIA CLUB.
2001 Company acquired Sarah-James .com n Australia and published the Complete History and Concepts of Refractive Surgery. It published Zen and the Art of Seeing.

 Eukaryotic chromosomes terminate with specific structures known as telomeres which permit the complete replication of chromosome ends and which also provide them with a protective "cap." The former role is achieved by the enzyme telomerase, a specialized reverse transcriptase that synthesizes a short DNA sequence directly onto the chromosomal terminus

 



Selected Categories:
Product Company   Service Company
Biopharma
- Research
Biotech
- Research
Diagnostics
- Medical
Supplier
- Research
Consulting
- Research
- Software
Laboratory
- Analytical

Last update of this entry: October 25, 2022

   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2024 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.